Skip to main content

Table 1 Sociodemographic and clinical characteristics for 621 patients across languages and in total

From: Patient-reported anxiety and depression measures for use in Indian head and neck cancer populations: a psychometric evaluation

Socio demographics

Tamil (n = 205)

Telugu (n = 216)

Hindi (n = 200)

Total (n = 621)

Age: Mean, Median (Range)

52.83, 54 (19–82)

50.5, 49 (21–89)

45.98, 45 (21–75)

49.77, 49 (19–89)

 Missing

1

3

0

4

Gender n (%)

 Male

163 (79.5)

170 (78.7)

173 (86.5)

506 (81.5)

 Female

41 (20)

42 (19.4)

26 (13)

108 (17.5)

 Missing

1 (0.5)

4 (1.9)

1 (0.5)

6 (1)

Marital Status n (%)

 Married/De facto

183 (89.2)

169 (78.2)

184 (92)

536 (86.3)

 Divorced/Separated

3 (1.5)

7 (3.2)

1 (0.5)

11 (1.7)

 Single

6 (2.9)

8 (3.7)

13 (6.5)

27 (4.4)

 Widowed

11 (5.4)

27 (12.5)

2 (1)

40 (6.4)

 Missing

2 (1)

5 (2.3)

0

7 (1.1)

Education qualification n (%)

 Primary level

60 (29.3)

127 (58.8)

74 (37)

261 (42)

 Intermediate level

78 (38)

28 (13)

46 (23)

152 (24.5)

 Higher secondary level

39 (19)

27 (12.5)

26 (13)

92 (14.8)

 Diploma

10 (4.9)

21 (9.7)

0 (0)

31 (5)

 University degree

14 (6.8)

10 (4.6)

44 (22)

68 (11)

 Post graduate degree

1 (0.5)

3 (1.4)

9 (4.5)

13 (2.1)

 Missing

3 (1.5)

0

1 (0.5)

4 (0.6)

Employment n (%)

 Employed

141 (68.7)

106 (49.07)

153 (76.5)

400 (64.4)

 Unemployed

23 (11.2)

80 (37)

20 (10)

123 (19.8)

 Homemaker

23 (11.2)

20 (9.2)

17 (8.5)

60 (9.7)

 Training/education

1 (0.5)

2 (0.9)

4 (2)

7 (1.1)

 Retired

1 (0.5)

1 (0.5)

5 (2.5)

7 (1.1)

 Unable to work

13 (6.3)

1 (0.5)

0 (0)

14 (2.2)

 Other

0

1 (0.5)

1 (0.5)

2 (0.3)

 Missing

3 (1.5)

5 (2.3)

0

8 (1.3)

Type of Cancer n (%)

 Oral Cavity

94 (45.8)

108 (50)

181 (90.5)

383 (61.7)

 Salivary Gland

2 (0.9)

6 (2.8)

1 (0.5)

9 (1.4)

 Oropharynx

26 (12.6)

3 (1.4)

2 (1)

31 (5)

 Larynx + Hypopharynx

35 (17.1)

9 (4.2)

0 (0)

44 (7.1)

 Sinus gland

2 (0.9)

1 (0.5)

0 (0)

3 (0.5)

 Tongue

35 (17.1)

35 (16.2)

9 (4.5)

79 (12.7)

 Nasopharynx

9 (4.4)

7 (3.2)

0 (0)

16 (2.6)

 Nasal Cavity

0

29 (13.4)

4 (2)

33 (5.3)

 Unknown primary

1 (0.5)

11 (5.1)

0 (0)

12 (1.9)

 Missing

1 (0.5)

7 (3.2)

3 (1.5)

11 (1.8)

Stage of disease n (%)

 I

3 (1.4)

8 (3.7)

14 (7)

25 (4)

 II

34 (16.5)

24 (11.1)

63 (31.5)

121 (19.5)

 III

114 (55.6)

69 (31.9)

84 (42)

267 (42.9)

 IV

43 (20.9)

19 (8.8)

31 (15.5)

93 (14.9)

 Missing

11 (5.3)

96 (44.4)

8 (4)

115 (18.5)

Treatment offered n (%)

 Radiation

205 (100)

177 (81.9)

199 (99.5)

581 (93.6)

 Chemotherapy

198 (96.6)

121 (56)

33 (16.5)

352 (56.7)

 Surgery

29 (14.1)

32 (14.8)

115 (57.5)

176 (28.3)

Treatment status n (%)

 Undergoing treatment

104 (50.7)

177 (81.9)

189 (94.5)

470 (75.7)

 Survivor

97 (47.3)

39 (18.1)

11 (5.5)

150 (24.1)

Substance usage n (%)

 Yes

150 (73.2)

187 (86.5)

190 (95)

527 (84.8)

 No

54 (26.3)

20 (9.2)

9 (4.5)

83 (13.3)

 Missing

1 (0.5)

9 (4.1)

1 (0.5)

11 (1.7)

ECOG Performance Status n (%)

 0

51 (24.8)

25 (11.6)

99 (49.5)

175 (28.1)

 1

110 (53.6)

75 (34.7)

77 (38.5)

262 (42.2)

 2

23 (11.2)

71 (32.9)

17 (8.5)

111 (17.9)

 3

16 (7.8)

26 (12)

5 (2.5)

47 (7.6)

 4

4 (1.9)

13 (6.0)

1 (0.5)

18 (2.9)

 Missing

1 (0.4)

6 (2.8)

1 (0.5)

8 (1.3)